Godavari Drugs Limited (BOM:530317)

Godavari Drugs Statistics

Total Valuation

Godavari Drugs has a market cap or net worth of INR 687.01 million. The enterprise value is 1.40 billion.

Market Cap	687.01M
Enterprise Value	1.40B

Important Dates

The next estimated earnings date is Saturday, February 14, 2026.

Earnings Date	Feb 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Godavari Drugs has 7.53 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	7.53M
Shares Outstanding	7.53M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	-0.22%
Owned by Insiders (%)	58.36%
Owned by Institutions (%)	n/a
Float	2.84M

Valuation Ratios

The trailing PE ratio is 18.55.

PE Ratio	18.55
Forward PE	n/a
PS Ratio	0.65
PB Ratio	1.51
P/TBV Ratio	1.51
P/FCF Ratio	n/a
P/OCF Ratio	4.63
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.18, with an EV/FCF ratio of -19.23.

EV / Earnings	37.91
EV / Sales	1.32
EV / EBITDA	12.18
EV / EBIT	15.59
EV / FCF	-19.23

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.63.

Current Ratio	1.05
Quick Ratio	0.52
Debt / Equity	1.63
Debt / EBITDA	6.42
Debt / FCF	-10.13
Interest Coverage	2.18

Financial Efficiency

Return on equity (ROE) is 8.50% and return on invested capital (ROIC) is 6.34%.

Return on Equity (ROE)	8.50%
Return on Assets (ROA)	3.88%
Return on Invested Capital (ROIC)	6.34%
Return on Capital Employed (ROCE)	11.53%
Weighted Average Cost of Capital (WACC)	4.64%
Revenue Per Employee	10.01M
Profits Per Employee	349,236
Employee Count	106
Asset Turnover	0.73
Inventory Turnover	2.80

Taxes

In the past 12 months, Godavari Drugs has paid 10.83 million in taxes.

Income Tax	10.83M
Effective Tax Rate	22.63%

Stock Price Statistics

The stock price has decreased by -20.98% in the last 52 weeks. The beta is 0.13, so Godavari Drugs's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-20.98%
50-Day Moving Average	80.49
200-Day Moving Average	86.83
Relative Strength Index (RSI)	58.75
Average Volume (20 Days)	16,495

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Godavari Drugs had revenue of INR 1.06 billion and earned 37.02 million in profits. Earnings per share was 4.92.

Revenue	1.06B
Gross Profit	270.08M
Operating Income	89.99M
Pretax Income	47.85M
Net Income	37.02M
EBITDA	115.23M
EBIT	89.99M
Earnings Per Share (EPS)	4.92

Balance Sheet

The company has 22.93 million in cash and 739.28 million in debt, with a net cash position of -716.35 million or -95.13 per share.

Cash & Cash Equivalents	22.93M
Total Debt	739.28M
Net Cash	-716.35M
Net Cash Per Share	-95.13
Equity (Book Value)	453.87M
Book Value Per Share	60.32
Working Capital	39.82M

Cash Flow

In the last 12 months, operating cash flow was 148.30 million and capital expenditures -221.27 million, giving a free cash flow of -72.97 million.

Operating Cash Flow	148.30M
Capital Expenditures	-221.27M
Free Cash Flow	-72.97M
FCF Per Share	-9.69

Margins

Gross margin is 25.44%, with operating and profit margins of 8.48% and 3.49%.

Gross Margin	25.44%
Operating Margin	8.48%
Pretax Margin	4.51%
Profit Margin	3.49%
EBITDA Margin	10.86%
EBIT Margin	8.48%
FCF Margin	n/a

Dividends & Yields

Godavari Drugs does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	5.39%
FCF Yield	-10.62%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4